Cargando…
Direct-Acting Antiviral Therapy and Risk of Hepatocellular Carcinoma Recurrence in Patients with Chronic Hepatitis C
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Editorial Office of Gut and Liver
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129652/ https://www.ncbi.nlm.nih.gov/pubmed/33988131 http://dx.doi.org/10.5009/gnl210191 |
| _version_ | 1783694342590824448 |
|---|---|
| author | Lee, Chang Hun Kim, In Hee |
| author_facet | Lee, Chang Hun Kim, In Hee |
| author_sort | Lee, Chang Hun |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8129652 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Editorial Office of Gut and Liver |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-81296522021-05-24 Direct-Acting Antiviral Therapy and Risk of Hepatocellular Carcinoma Recurrence in Patients with Chronic Hepatitis C Lee, Chang Hun Kim, In Hee Gut Liver Editorial Editorial Office of Gut and Liver 2021-05-15 2021-05-15 /pmc/articles/PMC8129652/ /pubmed/33988131 http://dx.doi.org/10.5009/gnl210191 Text en Copyright © Gut and Liver. https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Editorial Lee, Chang Hun Kim, In Hee Direct-Acting Antiviral Therapy and Risk of Hepatocellular Carcinoma Recurrence in Patients with Chronic Hepatitis C |
| title | Direct-Acting Antiviral Therapy and Risk of Hepatocellular Carcinoma Recurrence in Patients with Chronic Hepatitis C |
| title_full | Direct-Acting Antiviral Therapy and Risk of Hepatocellular Carcinoma Recurrence in Patients with Chronic Hepatitis C |
| title_fullStr | Direct-Acting Antiviral Therapy and Risk of Hepatocellular Carcinoma Recurrence in Patients with Chronic Hepatitis C |
| title_full_unstemmed | Direct-Acting Antiviral Therapy and Risk of Hepatocellular Carcinoma Recurrence in Patients with Chronic Hepatitis C |
| title_short | Direct-Acting Antiviral Therapy and Risk of Hepatocellular Carcinoma Recurrence in Patients with Chronic Hepatitis C |
| title_sort | direct-acting antiviral therapy and risk of hepatocellular carcinoma recurrence in patients with chronic hepatitis c |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129652/ https://www.ncbi.nlm.nih.gov/pubmed/33988131 http://dx.doi.org/10.5009/gnl210191 |
| work_keys_str_mv | AT leechanghun directactingantiviraltherapyandriskofhepatocellularcarcinomarecurrenceinpatientswithchronichepatitisc AT kiminhee directactingantiviraltherapyandriskofhepatocellularcarcinomarecurrenceinpatientswithchronichepatitisc |